X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
trichlormethiazide - therapeutic use (106) 106
humans (102) 102
male (90) 90
female (75) 75
hypertension - drug therapy (61) 61
middle aged (53) 53
adult (42) 42
aged (42) 42
blood pressure - drug effects (34) 34
antihypertensive agents - therapeutic use (26) 26
animals (25) 25
diuretics (25) 25
rats (25) 25
hypertension - physiopathology (23) 23
trichlormethiazide - administration & dosage (22) 22
diuretics - therapeutic use (21) 21
trichlormethiazide - pharmacology (21) 21
peripheral vascular disease (18) 18
trichlormethiazide (18) 18
hypertension (17) 17
calcium - urine (16) 16
sodium chloride symporter inhibitors - therapeutic use (16) 16
drug therapy, combination (15) 15
index medicus (14) 14
pharmacology & pharmacy (13) 13
blood pressure (12) 12
calcium channel blockers - therapeutic use (11) 11
heart rate - drug effects (11) 11
furosemide - therapeutic use (10) 10
hypertension - complications (10) 10
trichlormethiazide - adverse effects (10) 10
blood-pressure (9) 9
rats, inbred shr (9) 9
time factors (9) 9
treatment outcome (9) 9
allopurinol - therapeutic use (8) 8
chlorthalidone - therapeutic use (8) 8
furosemide - pharmacology (8) 8
potassium - blood (8) 8
angiotensin ii type 1 receptor blockers - therapeutic use (7) 7
double-blind method (7) 7
hydrochlorothiazide (7) 7
kidney calculi - drug therapy (7) 7
nicardipine - therapeutic use (7) 7
recurrence (7) 7
uric acid - blood (7) 7
uric acid - urine (7) 7
urology & nephrology (7) 7
administration, oral (6) 6
adolescent (6) 6
antihypertensive agents - administration & dosage (6) 6
antihypertensive agents - pharmacology (6) 6
calcium - metabolism (6) 6
diuretics - administration & dosage (6) 6
diuretics - pharmacology (6) 6
dose-response relationship, drug (6) 6
hydrochlorothiazide - therapeutic use (6) 6
hypertension - metabolism (6) 6
medicine, general & internal (6) 6
spironolactone - therapeutic use (6) 6
blood urea nitrogen (5) 5
calcium channel blockers - administration & dosage (5) 5
clinical trials as topic (5) 5
cross-over studies (5) 5
diazoxide - therapeutic use (5) 5
dihydropyridines - therapeutic use (5) 5
disease models, animal (5) 5
diuretic (5) 5
drug therapy (5) 5
enalapril - therapeutic use (5) 5
heart failure - drug therapy (5) 5
hypertension - chemically induced (5) 5
medicine & public health (5) 5
oxidative stress (5) 5
parathyroid hormone - blood (5) 5
pregnancy (5) 5
prospective studies (5) 5
rats, wistar (5) 5
sodium - blood (5) 5
tetrazoles - therapeutic use (5) 5
adenosine a (4) 4
adenosine a1-receptor antagonist (4) 4
age factors (4) 4
amiloride - therapeutic use (4) 4
angiotensin-converting enzyme inhibitors - therapeutic use (4) 4
antihypertensive drugs (4) 4
azetidinecarboxylic acid - analogs & derivatives (4) 4
azetidinecarboxylic acid - therapeutic use (4) 4
calcium - blood (4) 4
captopril - therapeutic use (4) 4
cardiac & cardiovascular systems (4) 4
chlorothiazide (4) 4
complications and side effects (4) 4
creatinine - blood (4) 4
desoxycorticosterone (4) 4
diabetes insipidus - drug therapy (4) 4
dogs (4) 4
dosage and administration (4) 4
drug combinations (4) 4
drug synergism (4) 4
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (97) 97
Japanese (20) 20
German (4) 4
Italian (3) 3
Danish (2) 2
Spanish (2) 2
Chinese (1) 1
Norwegian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical and Experimental Hypertension, ISSN 1064-1963, 07/2018, Volume 40, Issue 5, pp. 468 - 475
Journal Article
Journal Article
Journal of the American Society of Hypertension, ISSN 1933-1711, 2016, Volume 11, Issue 3, pp. 140 - 147
Journal Article
American Journal of Hypertension, ISSN 0895-7061, 5/2014, Volume 27, Issue 5, pp. 695 - 701
Journal Article
PLoS ONE, ISSN 1932-6203, 05/2015, Volume 10, Issue 5, p. e0125519
Objective This study compared the efficacy and safety of azelnidipine with that of trichlormethiazide in Japanese type 2 diabetic patients with hypertension.... 
AMLODIPINE | COMBINATION | IRBESARTAN | MULTIDISCIPLINARY SCIENCES | Calcium Channel Blockers - adverse effects | Dihydropyridines - administration & dosage | Humans | Middle Aged | Calcium Channel Blockers - therapeutic use | Hypertension - drug therapy | Male | Azetidinecarboxylic Acid - adverse effects | Azetidinecarboxylic Acid - analogs & derivatives | Dihydropyridines - adverse effects | Trichlormethiazide - adverse effects | Azetidinecarboxylic Acid - therapeutic use | Trichlormethiazide - therapeutic use | Female | Blood Pressure - drug effects | Diabetes Mellitus, Type 2 - complications | Diuretics - administration & dosage | Trichlormethiazide - administration & dosage | Japan | Risk Factors | Treatment Outcome | Dihydropyridines - therapeutic use | Calcium Channel Blockers - administration & dosage | Hypertension - complications | Diuretics - therapeutic use | Aged | Diabetes Mellitus, Type 2 - drug therapy | Diuretics - adverse effects | Azetidinecarboxylic Acid - administration & dosage | Hypertension | Type 2 diabetes | Trichlormethiazide | Dosage and administration | Research | Diagnosis | Drug therapy | Comparative analysis | Diabetic retinopathy | Edema | Diabetes mellitus | Clinical trials | Glucose | Metabolism | Patients | Insulin | Blood | Medicine | Hospitals | Older people | Diuretics | Blood pressure | Hypoglycemic agents | Diabetes | Health risk assessment | Drug dosages | Endocrinology
Journal Article
Journal Article
American Journal of Hypertension, ISSN 0895-7061, 01/2008, Volume 21, Issue 1, pp. 72 - 77
Background Angiotensin II (Ang II) receptor blocker (ARB) has been reported to have protective effects on the cardiovascular system independent of blood... 
MYOCARDIAL-INFARCTION | OXIDASE | RENIN-ANGIOTENSIN SYSTEM | DISEASE | GENE-EXPRESSION | RATS | STEM-CELL | PERIPHERAL VASCULAR DISEASE | NEOVASCULARIZATION | STRESS | NEOINTIMA | Antihypertensive Agents - pharmacology | Tetrazoles - pharmacology | Angiotensin II Type 1 Receptor Blockers - therapeutic use | NADPH Oxidases - metabolism | Hypertension - drug therapy | Male | Vascular Endothelial Growth Factor A - metabolism | Aorta - metabolism | Spin Labels | RNA, Messenger - metabolism | Vascular Endothelial Growth Factor A - genetics | Angiotensin II Type 1 Receptor Blockers - pharmacology | Cyclic N-Oxides - pharmacology | Myocardium - metabolism | NADPH Oxidases - genetics | Trichlormethiazide - pharmacology | Benzimidazoles - therapeutic use | Disease Models, Animal | Endothelial Cells - metabolism | Rats | Antihypertensive Agents - therapeutic use | Hypertension - metabolism | Cell Movement - drug effects | Chemokine CXCL12 - metabolism | Benzimidazoles - pharmacology | Oxidative Stress - drug effects | Endothelial Cells - enzymology | Sodium Chloride, Dietary - administration & dosage | Rats, Inbred WKY | Proto-Oncogene Proteins c-kit - metabolism | Stem Cells - metabolism | Chemokine CXCL12 - genetics | Stem Cells - enzymology | Proto-Oncogene Proteins c-kit - genetics | Blood Pressure - drug effects | Aorta - enzymology | Rats, Inbred SHR | Diuretics - pharmacology | Aorta - drug effects | Cells, Cultured | Renin-Angiotensin System - genetics | Thiobarbituric Acid Reactive Substances - metabolism | Antioxidants - pharmacology | Hypertension - physiopathology | Antioxidants - therapeutic use | Myocardium - enzymology | Animals | Stem Cells - drug effects | Renin-Angiotensin System - drug effects | Tetrazoles - therapeutic use | Cell Proliferation - drug effects | Endothelial Cells - drug effects | Hypertension | Physiological aspects | Oxidation-reduction reaction | Angiotensin II receptor blockers | Endothelium
Journal Article
The American Journal of the Medical Sciences, ISSN 0002-9629, 05/2010, Volume 339, Issue 5, pp. 433 - 439
Journal Article
Journal Article